# U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne

> **NCT01446237** · NA · COMPLETED · sponsor: **Stiefel, a GSK Company** · enrollment: 125 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **OTHER:** acne system - benzoyl peroxide 2.5%, Salicyclic Acid 0.5%

## Key facts

- **NCT ID:** NCT01446237
- **Lead sponsor:** Stiefel, a GSK Company
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06-01
- **Primary completion:** 2011-12-01
- **Final completion:** 2011-12-15
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2017-05-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01446237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01446237, "U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01446237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*